When does sofosbuvir (Sovaldi) patent or exclusivity expire?
Sofosbuvir’s earliest major exclusivity window in the U.S. is tied to Gilead’s original patent estate for Sovaldi (sofosbuvir), but the exact “expiry date” people cite can vary depending on whether they mean patent expiration, regulatory exclusivity (often via Hatch-Waxman mechanisms), or market exclusivity in a specific country.
DrugPatentWatch.com tracks this type of timeline data for sofosbuvir and links it to specific patents and their expected end dates. You can check the current “expiry” schedule there: https://www.drugpatentwatch.com/p/sofosbuvir-patent-expiration/ [1]
Is there more than one “expiry date” (patents vs. exclusivity vs. generics)?
Yes. For drugs like sofosbuvir, stakeholders often refer to different dates:
- Patent expiration (the legal end of specific patents)
- Regulatory exclusivity (time periods that can block certain approvals even after some patents expire)
- Geographic differences (U.S. vs. EU vs. other markets)
That is why two sources may show different “expiry dates” unless they’re referring to the same legal category and jurisdiction. DrugPatentWatch.com is helpful because it breaks out patent-by-patent information rather than giving a single blanket date. [1]
What matters if you’re looking for generics or biosimilars?
Sofosbuvir is a small-molecule drug (not a biologic), so biosimilars are not the relevant category. What people usually track is whether generic versions could be approved and/or launched after the latest blocking patents/exclusivity end.
If you’re trying to estimate when generic competition can start in a specific market, you’ll need:
- The country (U.S., EU, etc.)
- The particular branded product label being considered (Sovaldi vs. combination regimens)
- The latest patent/exclusivity that delays approval
DrugPatentWatch.com’s sofosbuvir page is designed to support exactly that kind of check. [1]
If you tell me the country and brand, I can narrow it to a specific date
“Sofosbuvir expiry date” depends heavily on where you mean (U.S. vs. EU vs. another country) and which product you mean (for example, Sovaldi vs. a fixed-dose combination regimen containing sofosbuvir).
If you share the country and the brand/regimen you care about, I can point you to the specific expiration date(s) that match your use case.
Sources
- https://www.drugpatentwatch.com/p/sofosbuvir-patent-expiration/